Contrafect Corp (CFRX): Vanguard Group Inc., Goldman Sachs Grou...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Contrafect Corp (CFRX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	120
Posts	2391
Boards Moderated	0
Alias Born	05/14/2014

Re: None

Wednesday, 01/25/2023 5:34:39 AM

Wednesday, January 25, 2023 5:34:39 AM

Vanguard Group Inc., Goldman Sachs Group Inc grew its stake ????
https://www.americanbankingnews.com/2023/01/17/contrafect-nasdaqcfrx-coverage-initiated-at-stocknews-com.html
Exebacase, a lysin, which is in "Phase III clinical trials" for the treatment of staphylococcus aureus bacteremia.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CFRX News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:24:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:41:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:30:55 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/03/2023 09:08:09 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/03/2023 04:16:01 AM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/30/2023 09:24:34 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/24/2023 08:06:07 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2023 08:05:56 PM
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study • GlobeNewswire Inc. • 10/16/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 03:15:52 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 12:00:18 PM
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development • GlobeNewswire Inc. • 09/19/2023 12:30:00 PM
ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370 • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/14/2023 08:05:49 PM
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023 • GlobeNewswire Inc. • 08/28/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:10:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:18:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:10:59 PM
ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2023 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 08:33:29 PM

More CFRX News

InvestorsHub NewsWire

FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow